Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1961 1
1966 1
1967 1
1969 2
1970 3
1971 1
1972 1
1973 2
1974 1
1976 2
1977 1
1978 1
1979 1
1980 4
1981 2
1982 5
1983 1
1984 3
1985 4
1986 5
1987 5
1988 5
1989 13
1990 9
1991 8
1992 5
1993 6
1994 9
1995 6
1996 4
1997 8
1998 11
1999 14
2000 14
2001 22
2002 17
2003 14
2004 15
2005 25
2006 17
2007 28
2008 25
2009 38
2010 37
2011 31
2012 28
2013 30
2014 46
2015 36
2016 39
2017 37
2018 56
2019 45
2020 65
2021 71
2022 69
2023 9
Text availability
Article attribute
Article type
Publication date

Search Results

845 results
Results by year
Filters applied: . Clear all
Page 1
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.
Asano K, Hebisawa A, Ishiguro T, Takayanagi N, Nakamura Y, Suzuki J, Okada N, Tanaka J, Fukutomi Y, Ueki S, Fukunaga K, Konno S, Matsuse H, Kamei K, Taniguchi M, Shimoda T, Oguma T; Japan ABPM Research Program. Asano K, et al. Among authors: kamei k. J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5. doi: 10.1016/j.jaci.2020.08.029. Epub 2020 Sep 10. J Allergy Clin Immunol. 2021. PMID: 32920094 Free article.
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinouchi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K; Japanese Study Group of Kidney Disease in Children. Iijima K, et al. Among authors: kamei k. J Am Soc Nephrol. 2022 Feb;33(2):401-419. doi: 10.1681/ASN.2021050643. Epub 2021 Dec 8. J Am Soc Nephrol. 2022. PMID: 34880074 Clinical Trial.
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
Chan EY, Yu ELM, Angeletti A, Arslan Z, Basu B, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Drovandi S, Ghiggeri GM, Gipson DS, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Saini P, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yap HK, Tullus K. Chan EY, et al. Among authors: kamei k. J Am Soc Nephrol. 2022 Jun;33(6):1193-1207. doi: 10.1681/ASN.2021111472. Epub 2022 Mar 30. J Am Soc Nephrol. 2022. PMID: 35354600
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Iijima K, et al. Among authors: kamei k. Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965823 Clinical Trial.
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai Hepatobiliary Oncology Group (KHBO). Ioka T, et al. Among authors: kamei k. J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110. doi: 10.1002/jhbp.1219. Epub 2022 Aug 9. J Hepatobiliary Pancreat Sci. 2023. PMID: 35900311 Clinical Trial.
[Investigation of Virulence Factors by "Omics" Approaches].
Takahashi-Nakaguchi A, Hagiwara D, Takahashi H, Sakai K, Toyotome T, Watanabe A, Kamei K, Gonoi T. Takahashi-Nakaguchi A, et al. Among authors: kamei k. Med Mycol J. 2018;59(2):J35-J40. doi: 10.3314/mmj.18.005. Med Mycol J. 2018. PMID: 29848910 Free article. Review. Japanese.
Microfluidic image cytometry.
Kamei K, Sun J, Tseng HR, Damoiseaux R. Kamei K, et al. Methods Mol Biol. 2011;706:191-206. doi: 10.1007/978-1-61737-970-3_16. Methods Mol Biol. 2011. PMID: 21104065
Unilateral motor weakness with kidney failure: Questions.
Suzuki R, Sato M, Ogura M, Murofushi Y, Abe Y, Kamei K. Suzuki R, et al. Among authors: kamei k. Pediatr Nephrol. 2021 Dec;36(12):4129-4130. doi: 10.1007/s00467-021-05169-7. Epub 2021 Sep 9. Pediatr Nephrol. 2021. PMID: 34499254 No abstract available.
845 results